It’s not a secret that many biotech companies are making hay as their share price is rising to new highs since COVID landed ashore the U.S. A quick scan of large cap companies will produce a number of these companies with Regeneron Pharmaceuticals Inc Stock (NASDAQ: REGN). While the amount of selling that’s occurring may not always be an indication to short, it is a warning of the likely overvaluation and there’s ways to take small risk trades with huge upside if they break. Regeneron has earnings coming up on August 5 and analysts are expecting a $0.04 decline in earnings year-over-yea...

With so many companies being given a pass this earnings season, unfortunately for investors Cameco Corp (NYSE: CCJ) wasn’t one of them. The company finished over 12% lower on the session and only minimally recovered off the low. While the company missed analyst estimates by a significant margin, there was a silver lining to the report and option traders may be seeing it based on Wednesday’s activity. The major culprit that impacted the earnings was an additional $37 million in care and maintenance costs associated with COVID. COVID-related issues extended to the closure of their Cigar L...

1 2 Insider trading can be a helpful tool for narrowing down the thousands of companies that you could potentially invest in. The degree of insider trading had escalated in recent months the trading is much more lopsided to selling over buying. That means that the companies that are seeing insiders buying their stock may be a good indicator of who’s buying the outlook. An “insider” was first defined in 1934 as an officer or director of a public company, or someone that owns 10% or more the company’s shares. Part of the 1934 act also required the disclosure of insider trading and how i...

AT&T Inc Stock (NYSE: T) finds itself trading at a similar level and valuation as it was in late 2018 and early 2019 when the stock price was at the same point. The company’s 7% dividend yield and Dividend Aristocrat status is definitely an attractive feature and has many longer-term income investors taking a closer look at this price. As the price floats near $30, at least one insider appears to have found a price their comfortable with. Stephen J. Luczo is a director for AT&T and has increased the size of his position in the company in recent months. On February 4, he added 10...

1 2 We’ve been down this road before. Traders getting excited, bullish option activity picks up and then…nothing. That was the tale of July 15. Many travel names began to surge, and option interest was high and very bullish. However, stocks don’t often run in a straight line and frequently the interest will build for a while before it begins to take off. On Tuesday, the options market was back at it for two airlines that are chomping at the bit for some normalization. You can understand the hesitation for companies and political leaders to fully reopen. There is a significant percenta...

Despite the SEC Wells Notice regarding its accounting treatment of sales covering 3Q 2015 through 4Q 2016, the price of Under Armour Inc (NYSE: UA) has continued to rise. As the price reaches the crossroads of its $10 resistance and its earnings report on July 31 before the market open, the call option activity is exploding. Current analyst expectations for Under Armour is a loss of $0.41, which is significantly lower than last year’s loss of $0.04. While the loss is to be expected, the guidance the company gives will be most important. The current quarter estimates have remained stable...

1 2 Next week is a huge week for the market with four of the top five largest companies are set to announce their earnings. Alongside those behemoths, there are many other companies that have market caps well into the mega cap territory that help us peer into the world of the consumer and the overall health of the economy. In the midst of COVID closures and many other complications, the mood of the market will largely depend on the guidance coming from these companies. As you consider expectations, there are a few areas to consider. The first is what analysts are currently expecting f...

1 2 As the S&P 500 continues to test it’s post-COVD highs and earnings season is upon us, it starts to open the door of possibility for a larger decline. There was the sell-off on June 11, 2020 that quickly found support and rallied, but the next sell-off may take the market much lower and may not recover quite as quickly. In the next downturn, it may not be the companies that have underperformed, but rather the ones that have outperformed that lead us lower. In fact, oversold companies with high dividends typically outperform in a down market. If you’re considering dividends, a g...

Paychex, Inc (NASDAQ: PAYX) is an integrated human capital management company. They assist small- to medium-sized businesses with payroll, human resource, retirement, and insurance services. The company reported their 4Q 2020 results on July 7. They reported a 7% decrease in revenue year-over-year and a decline of 5% in diluted earnings per share. In the last week, the company was one of the most-sold stock by insiders. The company has 10.85% insider ownership with over 98% of the ownership being held by Thomas Golisano with over 37.5 million shares. The institutional ownership is 40.91...

1 2 If you have been monitoring the many issues affecting healthcare right now, you know that healthcare businesses are really feeling the pinch. The inability to provide “elective” procedures and the fact people are staying home is really hurting their bottom line. In addition, the cost of a worker is increasing. Enter 5G and artificial intelligence. The bar has never been lower to replace now non-essential workers with technology. What 5G brings is the ability to transfer large amounts of data quickly. For systems relying on real time information and using it for patient care is hug...